Institute for Cancer Research

Kjetil Taskén
Instiute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

Annual report 2018 (pdf):
Abstract (in Norwegian)
Download in single page format - double page (broad) format

Publication overview

Current news and events

Peter Wiedswang employee of the year 2019 at the Institute for Cancer Research

Peter Wiedswang receiving the award from Institute head Kjetil Taskén
Peter Wiedswang receiving the award from Institute head Kjetil Taskén

Peter Wiedswang – Special advisor at the Institute of Cancer Research – was yesterday awarded the prize Employee-of-the-year 2019. The award committee and nomination describes Peter Wiedswang as an employee that always goes the extra mile for his colleges. Wiedswang works in the administration at the institute for Cancer Research where he is responsible for the budget and HR for three sections serving 13 group leaders. 

ERC Consolidator Grant of 20 million NOK awarded to Johanna Olweus

Johanna Olweus (photo: UiO)
Johanna Olweus (photo: UiO)

Professor Johanna Olweus - head of the Experimental Immunotherapy Group at the Department of Cancer Immunology - was awarded the Consolidator Grant from the European Research Council (ERC) for her project on immunotherapy “OUTSOURCE: Outsourcing cancer immunity to healthy donors”.

New immune-related breast cancer subtypes described in Nature Communications

First author Xavier Tekpli and senior author Vessela Kristensen
First author Xavier Tekpli and senior author Vessela Kristensen

In a study published December 3rd in Nature Communications, Xavier Tekpli in Vessela Kristensen’s group and their colleagues from the EMIT study report an immune-related breast cancer subtype which identifies patients with poor prognosis and in need of new treatment strategies.

Scientists from the EMIT study, from left to right:
Bjørn Naume, Therese Sørlie, Hege Russnes, Hege
Oma Ohnstad, Elin Borgen and Gry Aarum Geitvik.

 

 

Units and subpages

View all subunitsHide all subunits